It’s still a bull thesis, just subverted: Metlife Inc (MET)

Metlife Inc [MET] stock prices are up 1.49% to $69.95 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MET shares have lost -1.45% over the last week, with a monthly amount drifted -3.38%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Metlife Inc [NYSE: MET] stock has seen the most recent analyst activity on January 08, 2024, when Goldman upgraded its rating to a Buy but kept the price target unchanged to $80 for it. On October 05, 2023, Deutsche Bank initiated with a Hold rating and assigned a price target of $71 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $72 on September 14, 2023. Goldman downgraded its rating to a Neutral and reduced its price target to $78 on January 09, 2023. Jefferies downgraded its rating to Hold for this stock on December 09, 2022, and downed its price target to $82. In a note dated September 22, 2022, Raymond James initiated an Mkt Perform rating.

The stock price of Metlife Inc [MET] has been fluctuating between $48.95 and $74.68 over the past year. Currently, Wall Street analysts expect the stock to reach $84.73 within the next 12 months. Metlife Inc [NYSE: MET] shares were valued at $69.95 at the most recent close of the market. An investor can expect a potential return of 21.13% based on the average MET price forecast.

Analyzing the MET fundamentals

The Metlife Inc [NYSE:MET] reported sales of 66.91B for trailing twelve months, representing a surge of 16.62%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.05 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.63.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.47 points at the first support level, and at 68.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 70.29, and for the 2nd resistance point, it is at 70.63.

Ratios To Look Out For

It’s worth pointing out that Metlife Inc [NYSE:MET]’s Current Ratio is 3.91. Considering the valuation of this stock, the price to sales ratio is 0.76, the price to book ratio is 1.70 and price to earnings (TTM) ratio is 38.24.

Transactions by insiders

Recent insider trading involved PAPPAS BILL, EVP, Global Tech. & Ops., that happened on Mar 18 ’24 when 27000.0 shares were sold. President, U.S. Business, TADROS RAMY completed a deal on Mar 13 ’24 to sell 4026.0 shares. Meanwhile, President & CEO Khalaf Michel sold 20460.0 shares on Feb 05 ’24.

Related Posts